BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tanaka H, Tsuruga K, Aizawa-Yashiro T, Watanabe S, Imaizumi T. Treatment of young patients with lupus nephritis using calcineurin inhibitors. World J Nephrol 2012; 1(6): 177-183 [PMID: 24175257 DOI: 10.5527/wjn.v1.i6.177]
URL: https://www.wjgnet.com/2220-6124/full/v1/i6/177.htm
Number Citing Articles
1
H Tanaka, T Aizawa, S Watanabe, E Oki, K Tsuruga, T Imaizumi. Efficacy of mizoribine-tacrolimus-based induction therapy for pediatric lupus nephritisLupus 2014; 23(8): 813 doi: 10.1177/0961203314528553
2
Hiroshi Tanaka, Kensuke Joh, Tadaatsu Imaizumi. Treatment of pediatric-onset lupus nephritis: a proposal of optimal therapyClinical and Experimental Nephrology 2017; 21(5): 755 doi: 10.1007/s10157-017-1381-1
3
Yuichi Muraki, Shugo Mizuno, Kaname Nakatani, Hiroki Wakabayashi, Eiji� Ishikawa, Toshimitsu Araki, Akira Taniguchi, Shuji Isaji, Masahiro Okuda. Monitoring of peripheral blood cluster of differentiation 4+ adenosine triphosphate activity and CYP3A5 genotype to determine the pharmacokinetics, clinical effects and complications of tacrolimus in patients with autoimmune diseasesExperimental and Therapeutic Medicine 2017;  doi: 10.3892/etm.2017.5364
4
Xiaoyan Zhang, Ling Ji, Lichuan Yang, Xiaohong Tang, Wei Qin. The effect of calcineurin inhibitors in the induction and maintenance treatment of lupus nephritis: a systematic review and meta-analysisInternational Urology and Nephrology 2016; 48(5): 731 doi: 10.1007/s11255-015-1201-z
5
Yanxinli Han, Hongyu Sha, Lanqi Zhou, Yuan Yang, Yi Wang, Zhuowei Yu, Liru Qiu, Yu Zhang, Jianhua Zhou. A study of calcineurin inhibitors in comparison with intravenous cyclophosphamide for initial induction treatment of lupus nephritis class Ⅲ, Ⅳ, V in Chinese childrenLupus 2025; 34(9): 961 doi: 10.1177/09612033251351338
6
Chi Liu, Zhidan Wang, Xin Hu, Hidenori Ito, Kiwamu Takahashi, Motowo Nakajima, Tohru Tanaka, Ping Zhu, Xiao-Kang Li. 5-aminolevulinic acid combined with sodium ferrous citrate ameliorated lupus nephritis in a mouse chronic graft-versus-host disease modelInternational Immunopharmacology 2021; 96: 107626 doi: 10.1016/j.intimp.2021.107626
7
Kana N. Miyata, Hiromi Kihira, Manabu Haneda, Yasuhide Nishio. IgG4-Related Tubulointerstitial Nephritis Associated with Membranous Nephropathy in Two Patients: Remission after Administering a Combination of Steroid and MizoribineCase Reports in Nephrology 2014; 2014: 1 doi: 10.1155/2014/678538
8
Yumeng Zhang, Jin Zhao, Yunlong Qin, Yuwei Wang, Zixian Yu, Xiaoxuan Ning, Shiren Sun. Specific alterations of gut microbiota in patients with membranous nephropathy: A systematic review and meta-analysisFrontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.909491
9
Hiroshi Tanaka, Tomomi Aizawa, Morito Endo. Long‐term outcome of tacrolimus‐based immunosuppressive treatment for patients with paediatric‐onset lupus nephritisNephrology 2024; 29(12): 901 doi: 10.1111/nep.14406
10
Yukihiko Kawasaki, Shinichiro Ohara, Kyohei Miyazaki, Shuto Kanno, Atsushi Ono, Kazuhide Suyama, Masatoki Sato, Shigeo Suzuki, Ryo Maeda, Katsutoshi Nagasawa, Mitsuaki Hosoya. Incidence and prognosis of systemic lupus erythematosus in a 35 year period in Fukushima, JapanPediatrics International 2015; 57(4): 650 doi: 10.1111/ped.12588
11
Dionysis Nikolopoulos, Lampros Fotis, Ourania Gioti, Antonis Fanouriakis. Tailored treatment strategies and future directions in systemic lupus erythematosusRheumatology International 2022; 42(8): 1307 doi: 10.1007/s00296-022-05133-0
12
Daniela S. Ardelean, Michelle Letarte. Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasiaFrontiers in Genetics 2015; 6 doi: 10.3389/fgene.2015.00035
13
D. Roselyn Cerutis. Reference Module in Biomedical Sciences2014;  doi: 10.1016/B978-0-12-801238-3.05336-8